The independent source for health policy research, polling, and news.
38,101 - 38,120 of 112,572 Results
The lawmakers say they support the effort but think the ratings do not adequately assess hospitals that deal with large numbers of low-income patients or chronic, complex problems.
The groups are urging lawmakers to reject the Trans-Pacific Partnership deal because "it would lock in policies that keep prices of too many medicines unaffordably high."
The filing deadline was Tuesday for the briefs in the case concerning the federal government's mandatory contraception coverage requirements. The challengers proposed that insurance companies create stand-alone contraception plans. The Obama administration says such plans would "impose logistical obstacles on women seeking contraceptive coverage” and was “inconsistent with federal and state insurance law.”
More than 60 nonprofit groups and medical experts have sent a letter to the agency that accredits U.S. hospitals, asking it to revise its standards for pain management. They say that doctors routinely ask patients to assess their pain, which is leading to too many prescriptions for opioids.
President Barack Obama is expected to sign the legislation, which allows the Food and Drug Administration to include Zika drug developers in the agency's priority review voucher program. However, the measure comes with no extra funding to battle the virus.
Sean Parker, the co-founder of Napster, is creating the Parker Institute for Cancer Immunotherapy, which will focus on collaboration between scientists in their efforts to unlock the body's own immune system to fight cancer.
Gov. Asa Hutchinson says if the legislature fails to approve his efforts to keep and revamp the expanded Medicaid program, the remaining budget gap will prevent him from moving forward on plans for new highways. Meanwhile, in Maine, the state Senate approved Medicaid expansion by one vote and South Dakota officials are still planning for an expansion.
Premiums have gone up 8 percent, and when subsidies were factored in the increase was even smaller at 4 percent. The report counters predictions that premiums would see double-digit jumps.
Today's early morning highlights from the major news organizations.
A selection of opinions from around the country.
Columnists and editorial writers examine and review various aspects of the federal health law and its Massachusetts predecessor, which is now celebrating its 10th anniversary.
News outlets report on health issues in Arizona, Florida, Wisconsin, North Carolina, Missouri, North Dakota, New Hampshire, Tennessee, South Carolina, Maryland, Nebraska and Hawaii.
Meanwhile, N.C. Gov. Pat McCrory hopes to increase the state's spending on mental health, a judge in Washington orders a partial shutdown of a treatment facility for mentally ill defendants because of safety risks and inpatient psychiatric beds are scarce in California.
Gov. Rick Snyder claims that he had been assured that outside experts were wrong about the crisis in Flint. Elsewhere, health-related water problems have also emerged in New Hampshire and Florida.
There have been no reported fentanyl-related overdoses in nearly a week, following a spree that struck Sacramento County in late March. Elsewhere, The Tennessean takes a look at the state's continuing opioid problem.
Other outlets also report on Medicaid developments in Connecticut, Kansas and Arkansas.
Some women tell stories of loss, others of certainty. But they all want to make sure the Supreme Court justices deciding on Whole Woman’s Health v. Hellerstedt know how abortion affected each of their lives.
The Washington Post offers seven ways to handle the financial toxicity and stress that can come with a cancer diagnosis. In other news, the Food and Drug Administration approves a drug that targets a hard-to-treat subset of leukemia.
Although many physicians are hopeful about the usefulness of new technology, they say that it shouldn't be a replacement for traditional care. "It's like having a really bad doctor," warns Dr. Karandeep Singh, a professor at the University of Michigan.
The drugmaker's chief executive says he wants to "set the record straight" that the company is not following in the path of former CEO Martin Shkreli, who infamously increased the price of life-saving drugs.
© 2026 KFF